These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

997 related articles for article (PubMed ID: 16990384)

  • 1. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.
    Schächinger V; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Hölschermann H; Yu J; Corti R; Mathey DG; Hamm CW; Süselbeck T; Assmus B; Tonn T; Dimmeler S; Zeiher AM;
    N Engl J Med; 2006 Sep; 355(12):1210-21. PubMed ID: 16990384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcoronary transplantation of progenitor cells after myocardial infarction.
    Assmus B; Honold J; Schächinger V; Britten MB; Fischer-Rasokat U; Lehmann R; Teupe C; Pistorius K; Martin H; Abolmaali ND; Tonn T; Dimmeler S; Zeiher AM
    N Engl J Med; 2006 Sep; 355(12):1222-32. PubMed ID: 16990385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
    Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
    Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.
    Lunde K; Solheim S; Aakhus S; Arnesen H; Abdelnoor M; Egeland T; Endresen K; Ilebekk A; Mangschau A; Fjeld JG; Smith HJ; Taraldsrud E; Grøgaard HK; Bjørnerheim R; Brekke M; Müller C; Hopp E; Ragnarsson A; Brinchmann JE; Forfang K
    N Engl J Med; 2006 Sep; 355(12):1199-209. PubMed ID: 16990383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction.
    Assmus B; Rolf A; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Tillmanns H; Yu J; Corti R; Mathey DG; Hamm CW; Süselbeck T; Tonn T; Dimmeler S; Dill T; Zeiher AM; Schächinger V;
    Circ Heart Fail; 2010 Jan; 3(1):89-96. PubMed ID: 19996415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.
    Tendera M; Wojakowski W; Ruzyłło W; Chojnowska L; Kepka C; Tracz W; Musiałek P; Piwowarska W; Nessler J; Buszman P; Grajek S; Breborowicz P; Majka M; Ratajczak MZ;
    Eur Heart J; 2009 Jun; 30(11):1313-21. PubMed ID: 19208649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging.
    Britten MB; Abolmaali ND; Assmus B; Lehmann R; Honold J; Schmitt J; Vogl TJ; Martin H; Schächinger V; Dimmeler S; Zeiher AM
    Circulation; 2003 Nov; 108(18):2212-8. PubMed ID: 14557356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial.
    Erbs S; Linke A; Schächinger V; Assmus B; Thiele H; Diederich KW; Hoffmann C; Dimmeler S; Tonn T; Hambrecht R; Zeiher AM; Schuler G
    Circulation; 2007 Jul; 116(4):366-74. PubMed ID: 17620510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.
    Meyer GP; Wollert KC; Lotz J; Steffens J; Lippolt P; Fichtner S; Hecker H; Schaefer A; Arseniev L; Hertenstein B; Ganser A; Drexler H
    Circulation; 2006 Mar; 113(10):1287-94. PubMed ID: 16520413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial.
    Schächinger V; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Hölschermann H; Yu J; Corti R; Mathey DG; Hamm CW; Süselbeck T; Werner N; Haase J; Neuzner J; Germing A; Mark B; Assmus B; Tonn T; Dimmeler S; Zeiher AM;
    Eur Heart J; 2006 Dec; 27(23):2775-83. PubMed ID: 17098754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of functional recovery after myocardial infarction of patients treated with bone marrow-derived stem cells after thrombolytic therapy.
    Miettinen JA; Ylitalo K; Hedberg P; Jokelainen J; Kervinen K; Niemelä M; Säily M; Koistinen P; Savolainen ER; Ukkonen H; Pietilä M; Airaksinen KE; Knuuti J; Vuolteenaho O; Mäkikallio TH; Huikuri HV
    Heart; 2010 Mar; 96(5):362-7. PubMed ID: 19910293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.
    Yao K; Huang R; Qian J; Cui J; Ge L; Li Y; Zhang F; Shi H; Huang D; Zhang S; Sun A; Zou Y; Ge J
    Heart; 2008 Sep; 94(9):1147-53. PubMed ID: 18381377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction.
    Yousef M; Schannwell CM; Köstering M; Zeus T; Brehm M; Strauer BE
    J Am Coll Cardiol; 2009 Jun; 53(24):2262-9. PubMed ID: 19520249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of intracoronary stem cell therapy after acute myocardial infarction.
    Wöhrle J; Merkle N; Mailänder V; Nusser T; Schauwecker P; von Scheidt F; Schwarz K; Bommer M; Wiesneth M; Schrezenmeier H; Hombach V
    Am J Cardiol; 2010 Mar; 105(6):804-12. PubMed ID: 20211323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction.
    Huikuri HV; Kervinen K; Niemelä M; Ylitalo K; Säily M; Koistinen P; Savolainen ER; Ukkonen H; Pietilä M; Airaksinen JK; Knuuti J; Mäkikallio TH;
    Eur Heart J; 2008 Nov; 29(22):2723-32. PubMed ID: 18845667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.
    Schächinger V; Assmus B; Britten MB; Honold J; Lehmann R; Teupe C; Abolmaali ND; Vogl TJ; Hofmann WK; Martin H; Dimmeler S; Zeiher AM
    J Am Coll Cardiol; 2004 Oct; 44(8):1690-9. PubMed ID: 15489105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging.
    Ruan W; Pan CZ; Huang GQ; Li YL; Ge JB; Shu XH
    Chin Med J (Engl); 2005 Jul; 118(14):1175-81. PubMed ID: 16117862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction.
    Nyolczas N; Gyöngyösi M; Beran G; Dettke M; Graf S; Sochor H; Christ G; Edes I; Balogh L; Krause KT; Jaquet K; Kuck KH; Benedek I; Hintea T; Kiss R; Préda I; Kotevski V; Pejkov H; Dudek D; Heba G; Sylven C; Charwat S; Jacob R; Maurer G; Lang I; Glogar D
    Am Heart J; 2007 Feb; 153(2):212.e1-7. PubMed ID: 17239678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone-marrow-derived cell transfer after ST-elevation myocardial infarction: lessons from the BOOST trial.
    Drexler H; Meyer GP; Wollert KC
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S65-8. PubMed ID: 16501634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long term follow-up on emergent intracoronary autologous bone marrow mononuclear cell transplantation for acute inferior-wall myocardial infarction].
    Huang RC; Yao K; Zou YZ; Ge L; Qian JY; Yang J; Yang S; Niu YH; Li YL; Zhang YQ; Zhang F; Xu SK; Zhang SH; Sun AJ; Ge JB
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1107-10. PubMed ID: 16796836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.